President Donald Trump has imposed a 100% tariff on brand-name drugs in an effort to reduce U.S. reliance on imports. The order cited national security concerns, but certain drugs are exempt, including generic drugs and orphan drugs. The lower 15% tariff will apply to drugs from the European Union, Japan, South Korea, or Switzerland and Liechtenstein. A pharmaceutical trade group defended the tariffs, stating that every dollar spent on tariffs can't be invested in communities across the country. The Supreme Court recently overturned the president's previous tariffs, which invoked the International Emergency Economic Powers Act.